Moreover, conditional knockout of Nrf1 (also called nfe2l1) in the liver, brain and bone results in non-alcoholic steatohepatitis (NASH) and hepatoma [21], [22], neurodegeneration [23], [24], and reduced bone size [25]. The gene discussed is NFE2L1; the disease is metabolic dysfunction-associated steatohepatitis.